Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-01 9:15 pm Purchase | 2026-04-27 | 13D | XOMA ROYALTY CORPORATION COMMO XOMA | LIGAND PHARMACEUTICALS INC LGND | 8,062,678 47.000% | 8,062,678 (New Position) | Filing History |
| 2026-05-01 08:51 am Purchase | 2026-03-31 | 13G | LIGAND PHARMACEUTICALS INC LGND | Vanguard Portfolio Management | 1,109,154 5.560% | 1,109,154 (New Position) | Filing History |
| 2026-05-01 08:39 am Purchase | 2026-03-31 | 13G | LIGAND PHARMACEUTICALS INC LGND | Vanguard Capital Management | 997,637 5.000% | 997,637 (New Position) | Filing History |
| 2026-03-27 10:32 am Sale | 2026-03-13 | 13G | LIGAND PHARMACEUTICALS INC LGND | VANGUARD GROUP INC | 0 0.000% | -1,876,514 (Position Closed) | Filing History |
| 2025-11-14 12:43 pm Sale | 2025-09-30 | 13G | LIGAND PHARMACEUTICALS INC LGND | JANUS HENDERSON GROUP PLC JHG | 1,042,378 5.300% | -18,356 (-1.73%) | Filing History |
| 2025-11-10 4:42 pm Purchase | 2025-11-06 | 13D | PELTHOS THERAPEUTICS INC PTHS | LIGAND PHARMACEUTICALS INC LGND | 5,189,177 49.900% | 261,309 (+5.30%) | Filing History |
| 2025-10-17 5:31 pm Sale | 2025-09-30 | 13G | LIGAND PHARMACEUTICALS INC LGND | BlackRock Inc. BLK | 2,839,251 14.500% | -106,688 (-3.62%) | Filing History |
| 2025-08-14 11:43 am Purchase | 2025-06-30 | 13G | LIGAND PHARMACEUTICALS INC LGND | JANUS HENDERSON GROUP PLC JHG | 1,060,734 5.500% | 32,668 (+3.18%) | Filing History |
| 2025-07-03 4:05 pm Purchase | 2025-07-01 | 13D | PELTHOS THERAPEUTICS INC PTHS | LIGAND PHARMACEUTICALS INC LGND | 4,927,868 49.900% | 4,927,868 (New Position) | Filing History |
| 2025-05-14 12:31 pm Purchase | 2025-03-31 | 13G | LIGAND PHARMACEUTICALS INC LGND | JANUS HENDERSON GROUP PLC JHG | 1,028,066 5.300% | 13,043 (+1.28%) | Filing History |
| 2025-02-14 12:36 pm Purchase | 2024-12-31 | 13G | LIGAND PHARMACEUTICALS INC LGND | JANUS HENDERSON GROUP PLC JHG | 1,015,023 5.400% | 5,929 (+0.59%) | Filing History |
| 2025-02-05 1:23 pm Sale | 2024-12-31 | 13G | LIGAND PHARMACEUTICALS INC LGND | BlackRock Inc. BLK | 2,945,939 15.600% | -16,155 (-0.55%) | Filing History |
| 2024-11-14 3:19 pm Sale | 2024-09-30 | 13G | LIGAND PHARMACEUTICALS INC LGND | JANUS HENDERSON GROUP PLC JHG | 1,009,094 5.500% | -334,060 (-24.87%) | Filing History |
| 2024-11-08 5:34 pm Sale | 2024-09-30 | 13G | LIGAND PHARMACEUTICALS INC LGND | GOLDMAN SACHS GROUP INC GS | 52,350 0.300% | -1,129,581 (-95.57%) | Filing History |
| 2024-11-01 4:07 pm Sale | 2024-09-30 | 13G | LIGAND PHARMACEUTICALS INC LGND | MACQUARIE GROUP LTD | 887,275 4.860% | -99,973 (-10.13%) | Filing History |
| 2024-02-14 06:26 am Sale | 2023-12-31 | 13G | LIGAND PHARMACEUTICALS INC LGND | MACQUARIE GROUP LTD | 987,248 5.660% | -14,577 (-1.46%) | Filing History |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | LIGAND PHARMACEUTICALS INC LGND | VANGUARD GROUP INC | 1,876,514 10.760% | 33,399 (+1.81%) | Filing History |
| 2024-02-13 3:39 pm Purchase | 2023-12-31 | 13G | LIGAND PHARMACEUTICALS INC LGND | JANUS HENDERSON GROUP PLC JHG | 1,343,154 7.700% | 87,881 (+7.00%) | Filing History |
| 2024-02-12 7:42 pm Purchase | 2023-12-29 | 13G | LIGAND PHARMACEUTICALS INC LGND | GOLDMAN SACHS GROUP INC GS | 1,181,931 6.800% | 1,181,931 (New Position) | Filing History |
| 2024-01-22 2:03 pm Purchase | 2023-12-31 | 13G | LIGAND PHARMACEUTICALS INC LGND | BlackRock Inc. BLK | 2,962,094 17.000% | 172,615 (+6.19%) | Filing History |